Pricey hepatitis C drug may be good value
Despite its $7,000-per-week cost, sofosbuvir provides better value than other current treatments for prisoners with hepatitis C, according to Stanford researchers.
Competition keeps health-care costs low, researchers find
Physician practices in areas with low competition charge more for office visits than practices in areas with high competition.
'Brain on Fire': Susannah Cahalan and her month of madness
With the precision of an investigative journalist, Susannah Cahalan reconstructed what happened in her memoir, Brain on Fire: My Month of Madness.
Shaili Jain, MD, on her family legacy and PTSD
In her clinical practice, Shaili Jain, MD, works with veterans suffering from PTSD who are returning from the wars in Iraq and Afghanistan. She spearheads a pilot program based on veterans supporting veterans, aptly called the Peer Support Program.
Three faculty members elected to Institute of Medicine
Ben Barres, Paul Khavari and Brian Kobilka were among those announced Oct. 20 as new members of the prestigious institute.
Efforts to refine tools for recording brain activity get $1 million boost
The grant was part of $46 million handed out by the National Institutes of Health to support the goals of its BRAIN Initiative.
'Big ideas' in neuroscience take on stroke, addiction and more
An exercise inspires faculty to think broadly about the intersections of neuroscience with society, engineering, medicine and other fields.
Stem cells' rapid response due to short-lived RNA messages
Stem cells stay developmentally nimble by actively targeting key RNA messages for destruction. Researchers say this 'anti-epigenetics' works to ensure the transience of genetic information.
Wernig wins stem cell prize, Giocomo named neuroscience investigator
The New York Stem Cell Foundation awarded pathologist Marius Wernig $200,000 to pursue stem cell research, and neurobiologist Lisa Giocomo $1.5 million to expand her lab and train other scientists.
Stanford scientists awarded $18 million to accelerate rheumatoid arthritis, lupus research
P.J. Utz and William Robinson will spearhead efforts to accelerate research on two immune disorders: rheumatoid arthritis and lupus.
Decoy drug allows brains of adult mice to form new connections
If the discovery works in people, it has the potential to help adults recover from stroke and forms of blindness, and to prevent the loss of connections in Alzheimer's disease.
Leading the Biomedical Revolution
We are in the middle of a biomedical revolution more profound and far-reaching than the industrial and digital revolutions that made it possible.
A Legacy of Innovation
Stanford Medicine's unrivaled atmosphere of breakthrough thinking and interdisciplinary collaboration has fueled a long history of achievements.